Clinical significance of FBXW7 loss of function in human cancers
J Fan, M Bellon, M Ju, L Zhao, M Wei, L Fu, C Nicot - Molecular cancer, 2022 - Springer
Abstract FBXW7 (F-Box and WD Repeat Domain Containing 7)(also referred to as FBW7 or
hCDC4) is a component of the Skp1-Cdc53/Cullin-F-box-protein complex (SCF/β-TrCP). As …
hCDC4) is a component of the Skp1-Cdc53/Cullin-F-box-protein complex (SCF/β-TrCP). As …
Molecular biomarkers in acute myeloid leukemia
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The
pathophysiology of this disease is just beginning to be understood at the cellular and …
pathophysiology of this disease is just beginning to be understood at the cellular and …
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC
Background When a new pathogen, such as severe acute respiratory syndrome coronavirus
2, appears all novel information can aid in the process of monitoring and in the diagnosis of …
2, appears all novel information can aid in the process of monitoring and in the diagnosis of …
Nanomedicines for the treatment of hematological malignancies
AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid
M Karami Fath, J Azami, N Jaafari… - Cellular & Molecular …, 2022 - Springer
Exosomes, known as a type of extracellular vesicles (EVs), are lipid particles comprising
heterogeneous contents such as nucleic acids, proteins, and DNA. These bi-layered …
heterogeneous contents such as nucleic acids, proteins, and DNA. These bi-layered …
MicroRNA as a novel biomarker in the diagnosis of head and neck cancer
J Kabzinski, M Maczynska, I Majsterek - Biomolecules, 2021 - mdpi.com
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide, with
890,000 new cases and 450,000 deaths in 2018, and although the survival statistics for …
890,000 new cases and 450,000 deaths in 2018, and although the survival statistics for …
MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential
R Mardani, MH Jafari Najaf Abadi… - Journal of cellular …, 2019 - Wiley Online Library
Leukemia is known as a progressive malignant disease, which destroys the blood‐forming
organs and results in adverse effects on the proliferation and development of leukocytes and …
organs and results in adverse effects on the proliferation and development of leukocytes and …
MicroRNAs as biomarkers for clinical studies
IP Pogribny - Experimental Biology and Medicine, 2018 - journals.sagepub.com
The development of better diagnostic and prognostic non-invasive biomarkers holds an
enormous potential to improve the ability to diagnose and individualize treatment of a great …
enormous potential to improve the ability to diagnose and individualize treatment of a great …
Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
Early-stage detection of leukemia is a critical determinant for successful treatment of the
disease and can increase the survival rate of leukemia patients. The factors limiting the …
disease and can increase the survival rate of leukemia patients. The factors limiting the …
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state
A Ng, F Lovat, AJ Shih, Y Ma… - Proceedings of the …, 2023 - National Acad Sciences
Dysregulated apoptosis and proliferation are fundamental properties of cancer, and
microRNAs (miRNA) are critical regulators of these processes. Loss of miR-15a/16-1 at …
microRNAs (miRNA) are critical regulators of these processes. Loss of miR-15a/16-1 at …